The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

doi:10.1016/S2055-6640(20)30281-8

Editorial

. 2019 Jan 1;5(1):60-66.

doi: 10.1016/S2055-6640(20)30281-8.

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

Stephanie Popping¹, Debora Bade², Charles Boucher^{1

2}, Mark van der Valk³, Manal El-Sayed⁴, Olafsson Sigurour⁵, Vana Sypsa⁶, Timothy Morgan⁷, Amiran Gamkrelidze⁸, Constance Mukabatsinda⁹, Sylvie Deuffic-Burban¹⁰, Michael Ninburg¹¹, Jordan Feld¹², Margaret Hellard¹³, John Ward^{14

15}

Affiliations

¹ Department of Viroscience, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
² Virology Education, Utrecht, the Netherlands.
³ Amsterdam UMC location Meibergdreef, Amsterdam, the Netherlands.
⁴ Department of Pediatrics, Ain Shams University, Cairo, Egypt.
⁵ Division of Gastroenterology, Department of Medicine, Landspitali University Hospital, Reykjavik, Iceland.
⁶ Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
⁷ Gastroenterology Section, VA Long Beach Healthcare System, Long Beach, CA, USA.
⁸ National Center for Disease Control and Public Health, Tbilisi, Georgia.
⁹ Kigali University, Kigali, Rwanda.
¹⁰ Inserm, Université Paris Diderot, UFR de Médicine-site Bichart, Paris, France.
¹¹ World Hepatitis Alliance, London, UK.
¹² Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.
¹³ Disease Elimination Program, Burnet Institute, Melbourne, Australia.
¹⁴ National Center for HIV, Viral Hepatitis, STD, and TB, CDC, Atlanta, GA, USA.
¹⁵ Task Force for Global Health, Decatur, Atlanta, GA, USA.

PMID: 30800429
PMCID: PMC6362901
DOI: 10.1016/S2055-6640(20)30281-8

Editorial

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

Stephanie Popping et al. J Virus Erad. 2019.

. 2019 Jan 1;5(1):60-66.

doi: 10.1016/S2055-6640(20)30281-8.

Authors

Affiliations

¹ Department of Viroscience, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
² Virology Education, Utrecht, the Netherlands.
³ Amsterdam UMC location Meibergdreef, Amsterdam, the Netherlands.
⁴ Department of Pediatrics, Ain Shams University, Cairo, Egypt.
⁵ Division of Gastroenterology, Department of Medicine, Landspitali University Hospital, Reykjavik, Iceland.
⁶ Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Greece.
⁷ Gastroenterology Section, VA Long Beach Healthcare System, Long Beach, CA, USA.
⁸ National Center for Disease Control and Public Health, Tbilisi, Georgia.
⁹ Kigali University, Kigali, Rwanda.
¹⁰ Inserm, Université Paris Diderot, UFR de Médicine-site Bichart, Paris, France.
¹¹ World Hepatitis Alliance, London, UK.
¹² Toronto Centre for Liver Disease, Sandra Rotman Centre for Global Health, University of Toronto, Toronto, Canada.
¹³ Disease Elimination Program, Burnet Institute, Melbourne, Australia.
¹⁴ National Center for HIV, Viral Hepatitis, STD, and TB, CDC, Atlanta, GA, USA.
¹⁵ Task Force for Global Health, Decatur, Atlanta, GA, USA.

PMID: 30800429
PMCID: PMC6362901
DOI: 10.1016/S2055-6640(20)30281-8

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) affect more than 320 million people worldwide, which is more than HIV, tuberculosis (TB) and malaria combined. Elimination of HBV and HCV will, therefore, produce substantial public health and economic benefits and, most importantly, the prevention of 1.2 million deaths per year. In 2016, member states of the World Health Assembly unanimously adopted a resolution declaring that viral hepatitis should be eliminated by 2030. Currently, few countries have elimination programmes in place and even though the tools to achieve elimination are available, the right resources, commitments and allocations are lacking. During the fifth International Viral Hepatitis Elimination Meeting (IVHEM), 7-8 December 2018, Amsterdam, the Netherlands, an expert panel of clinicians, virologists and public health specialists discussed the current status of viral hepatitis elimination programmes across multiple countries, challenges in achieving elimination and the core indicators for monitoring progress, approaches that have failed and successful elimination plans.

Keywords: World Health Organization; elimination; hepatitis B virus; hepatitis C virus; viral hepatitis.

PubMed Disclaimer

Cited by

Post vaccination antibody titres of hepatitis B surface antigen (anti-HBs) in a mixed cohort of health care workers.
Lall M, Sen S, Patrikar S, Karade S, Gupta RM. Lall M, et al. Med J Armed Forces India. 2022 Apr;78(2):198-203. doi: 10.1016/j.mjafi.2020.11.023. Epub 2021 Feb 27. Med J Armed Forces India. 2022. PMID: 35463555 Free PMC article.
Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation.
Salum GM, El Meguid MA, Abelhafez TH, Medhat E, Abdel Aziz AO, Dawood R. Salum GM, et al. J Genet Eng Biotechnol. 2021 Nov 10;19(1):174. doi: 10.1186/s43141-021-00266-4. J Genet Eng Biotechnol. 2021. PMID: 34757522 Free PMC article.
Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway.
Hannula R, Söderholm J, Svendsen T, Skaland M, Nordbø SA, Steinum H, Damås JK. Hannula R, et al. Ther Adv Infect Dis. 2021 Oct 28;8:20499361211053929. doi: 10.1177/20499361211053929. eCollection 2021 Jan-Dec. Ther Adv Infect Dis. 2021. PMID: 34733508 Free PMC article.
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.
Schmidbauer C, Chromy D, Schmidbauer VU, Schwarz M, Jachs M, Bauer DJM, Binter T, Apata M, Nguyen DT, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Breuer M, Strassl R, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T. Schmidbauer C, et al. Liver Int. 2021 Nov;41(11):2622-2634. doi: 10.1111/liv.15018. Epub 2021 Aug 5. Liver Int. 2021. PMID: 34268869 Free PMC article.
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
Baliashvili D, Blumberg HM, Gandhi NR, Averhoff F, Benkeser D, Shadaker S, Gvinjilia L, Turdziladze A, Tukvadze N, Chincharauli M, Butsashvili M, Sharvadze L, Tsertsvadze T, Zarkua J, Kempker RR. Baliashvili D, et al. PLoS Med. 2023 May 4;20(5):e1004121. doi: 10.1371/journal.pmed.1004121. eCollection 2023 May. PLoS Med. 2023. PMID: 37141386 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization Global Hepatitis Report 2017. Geneva: 2017. Available at: www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ ( accessed January 2019).
1. Stanaway JD, Flaxman AD, Naghavi M et al. . The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016; 388: 1081– 1088. - PMC - PubMed
1. Lazarus JV, Stumo SR, Harris M et al. . Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc 2018; 21 Suppl 2: e25052. - PMC - PubMed
1. Pedrana A, Howell J, Schröder S et al. . Eliminating viral hepatitis: the investment case. World Innovation Summit for Health. November 2018. Doha, Qatar.
1. Ward JW, Hinman AR. What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats? Gastroenterology 2018; epub ahead of print. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] World Health Organization Global Hepatitis Report 2017. Geneva: 2017. Available at: www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ ( accessed January 2019).

[2] World Health Organization Global Hepatitis Report 2017. Geneva: 2017. Available at: www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ ( accessed January 2019).

[3] Stanaway JD, Flaxman AD, Naghavi M et al. . The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016; 388: 1081– 1088. - PMC - PubMed

[4] Stanaway JD, Flaxman AD, Naghavi M et al. . The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016; 388: 1081– 1088. - PMC - PubMed

[5] Lazarus JV, Stumo SR, Harris M et al. . Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc 2018; 21 Suppl 2: e25052. - PMC - PubMed

[6] Lazarus JV, Stumo SR, Harris M et al. . Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017. J Int AIDS Soc 2018; 21 Suppl 2: e25052. - PMC - PubMed

[7] Pedrana A, Howell J, Schröder S et al. . Eliminating viral hepatitis: the investment case. World Innovation Summit for Health. November 2018. Doha, Qatar.

[8] Pedrana A, Howell J, Schröder S et al. . Eliminating viral hepatitis: the investment case. World Innovation Summit for Health. November 2018. Doha, Qatar.

[9] Ward JW, Hinman AR. What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats? Gastroenterology 2018; epub ahead of print. - PubMed

[10] Ward JW, Hinman AR. What is needed to eliminate hepatitis B virus and hepatitis C virus as global health threats? Gastroenterology 2018; epub ahead of print. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

Affiliations

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Similar articles

Cited by

References

Publication types

Related information

LinkOut - more resources

Full Text Sources